Display options
Cite
Vervliet T, Gerasimenko JV, Ferdek PE, et al. BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis. Cell Death Discov. 2018;4:58doi: 10.1038/s41420-018-0054-5.
Vervliet, T., Gerasimenko, J. V., Ferdek, P. E., Jakubowska, M. A., Petersen, O. H., Gerasimenko, O. V., & Bultynck, G. (2018). BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis. Cell death discovery, 458. https://doi.org/10.1038/s41420-018-0054-5
Vervliet, Tim, et al. "BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis." Cell death discovery vol. 4 (2018): 58. doi: https://doi.org/10.1038/s41420-018-0054-5
Vervliet T, Gerasimenko JV, Ferdek PE, Jakubowska MA, Petersen OH, Gerasimenko OV, Bultynck G. BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis. Cell Death Discov. 2018 May 10;4:58. doi: 10.1038/s41420-018-0054-5. eCollection 2018. PMID: 29760956; PMCID: PMC5945673.
Copy Download .nbib Format: NLM
Share it on

Cell Death Discov. 2018 May 10;4:58. doi: 10.1038/s41420-018-0054-5. eCollection 2018.

BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis.

Cell death discovery

Tim Vervliet, Julia V Gerasimenko, Pawel E Ferdek, Monika A Jakubowska, Ole H Petersen, Oleg V Gerasimenko, Geert Bultynck

Affiliations

  1. 1Department of Cellular and Molecular Medicine, Laboratory of Molecular and Cellular Signaling, KU Leuven, Leuven, 3000 Belgium.
  2. 2Medical Research Council Group, Cardiff School of Biosciences, Cardiff University, Cardiff, CF10 3AX UK.

PMID: 29760956 PMCID: PMC5945673 DOI: 10.1038/s41420-018-0054-5

Abstract

Biliary acute pancreatitis (AP) is a serious condition, which currently has no specific treatment. Taurolithocholic acid 3-sulfate (TLC-S) is one of the most potent bile acids causing cytosolic Ca

Conflict of interest statement

The authors declare that they have no conflict of interest.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Biochem J. 2000 Oct 1;351(Pt 1):265-71 - PubMed
  2. Oncogene. 2003 Nov 20;22(52):8432-40 - PubMed
  3. J Vasc Res. 2004 Mar-Apr;41(2):202-7 - PubMed
  4. J Cell Biol. 2004 Jul 19;166(2):193-203 - PubMed
  5. Biochem Biophys Res Commun. 2004 Oct 15;323(2):473-8 - PubMed
  6. Eur J Cardiothorac Surg. 2005 Jan;27(1):117-21 - PubMed
  7. J Immunol. 2006 May 1;176(9):5471-7 - PubMed
  8. J Biol Chem. 2006 Dec 29;281(52):40154-63 - PubMed
  9. FEBS Lett. 2007 Feb 20;581(4):702-6 - PubMed
  10. Biochem Biophys Res Commun. 2007 Apr 6;355(2):501-7 - PubMed
  11. Annu Rev Physiol. 2008;70:273-99 - PubMed
  12. Mol Cell. 2008 Jul 25;31(2):255-65 - PubMed
  13. Perit Dial Int. 2008 Nov;28 Suppl 5:S48-52 - PubMed
  14. Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14397-402 - PubMed
  15. Cell Death Differ. 2012 Feb;19(2):295-309 - PubMed
  16. J Control Release. 2011 Dec 10;156(2):146-53 - PubMed
  17. Hum Mol Genet. 2012 Feb 15;21(4):826-40 - PubMed
  18. Adv Exp Med Biol. 2012;740:217-34 - PubMed
  19. Am J Physiol Gastrointest Liver Physiol. 2012 Jun 15;302(12):G1423-33 - PubMed
  20. J Clin Oncol. 2012 Sep 1;30(25):3127-35 - PubMed
  21. Curr Biol. 2012 Jul 10;22(13):1241-6 - PubMed
  22. J Physiol. 2014 Jan 15;592(2):269-80 - PubMed
  23. PLoS One. 2013 Aug 30;8(8):e73386 - PubMed
  24. Hum Mol Genet. 2014 Apr 1;23(7):1829-41 - PubMed
  25. J Med Chem. 2014 Aug 14;57(15):6275-88 - PubMed
  26. Biochim Biophys Acta. 2014 Oct;1843(10):2164-83 - PubMed
  27. J Cell Sci. 2014 Jun 15;127(Pt 12):2782-92 - PubMed
  28. Cell Calcium. 2014 Jun;55(6):346-54 - PubMed
  29. Biochim Biophys Acta. 2015 Sep;1854(9):1132-7 - PubMed
  30. J Biol Chem. 2015 Apr 3;290(14):9150-61 - PubMed
  31. Mol Cell. 2015 Mar 5;57(5):873-886 - PubMed
  32. Sci Rep. 2015 Apr 15;5:9641 - PubMed
  33. Gut. 2017 Feb;66(2):301-313 - PubMed
  34. Cell Death Dis. 2017 Mar 2;8(3):e2640 - PubMed
  35. Cell Calcium. 2018 Mar;70:95-101 - PubMed
  36. Cell Chem Biol. 2017 Aug 17;24(8):924-934 - PubMed
  37. FEBS J. 2018 Jan;285(1):127-145 - PubMed
  38. Cancer Res. 1994 May 1;54(9):2468-71 - PubMed
  39. Cancer Res. 1993 Oct 1;53(19):4701-14 - PubMed
  40. Cell. 1993 Oct 22;75(2):229-40 - PubMed

Publication Types